# First Affiliated Hospital of Fujian Medical University: Phase 2 study closed enrollment, 24 enrolled (Prostate Cancer)

**Score:** 70/100

| Field | Value |
|---|---|
| Sponsor | First Affiliated Hospital of Fujian Medical University |
| Sponsor type | Academic and hospital |
| Study | Phase 2 Clinical Trial of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer |
| NCT ID | NCT07117760 |
| Phase | Phase 2 |
| Status | active not recruiting |
| Conditions | Prostate Cancer |
| Intervention types | drug |
| Target enrollment | 24 |
| Site countries | China |
| Posted | 2025-08-12 |
| Planned start | 2025-04-22 |
| Event | Enrollment closed (active, not recruiting) |
| Event date | 2026-10-23 |
| Last update posted | 2026-10-23 |

## Why this score
- Posted in the last two weeks.
- Enrollment closed: data management, monitoring and closeout ahead.
- Phase 2: multi-site, larger budget.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07117760). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.